These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7891296)

  • 1. Pharmacokinetics of 5-carboranyl-2'-deoxyuridine in rats.
    Jarugula VR; Schinazi RF; Fulcrand G; el Kattan Y; Liotta DC; Boudinot FD
    J Pharm Sci; 1994 Dec; 83(12):1697-9. PubMed ID: 7891296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2'-deoxyuridine neutron capture therapy.
    Schinazi RF; Hurwitz SJ; Liberman I; Juodawlkis AS; Tharnish P; Shi J; Liotta DC; Coderre JA; Olson J
    Clin Cancer Res; 2000 Feb; 6(2):725-30. PubMed ID: 10690559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The boron-neutron capture agent beta-D-5-o-carboranyl-2'-deoxyuridine accumulates preferentially in dividing brain tumor cells.
    Moore C; Hernández-Santiago BI; Hurwitz SJ; Tan C; Wang C; Schinazi RF
    J Neurooncol; 2005 Sep; 74(3):275-80. PubMed ID: 16132519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular pharmacology of the D- and L-enantiomers of beta-5-o-carboranyl-2'-deoxyuridine.
    Hurwitz SJ; Ma L; Eleuteri A; Wright J; Moravek J; Schinazi RF
    Nucleosides Nucleotides Nucleic Acids; 2000 Mar; 19(3):691-702. PubMed ID: 10843501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular pharmacology and biological activity of 5-carboranyl-2'-deoxyuridine.
    Schinazi RF; Goudgaon NM; Fulcrand G; el Kattan Y; Lesnikowski Z; Ullas G; Moravek J; Liotta DC
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1113-20. PubMed ID: 8175396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic SIMS ion microscopy imaging of intracellular boron accumulation from carboranyl nucleosides in glioma cells.
    Gay I; Lorey DR; Schinazi RF; Morrison GH; Chandra S
    Anticancer Res; 2001; 21(4A):2369-75. PubMed ID: 11724295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.
    Hiramatsu R; Kawabata S; Tanaka H; Sakurai Y; Suzuki M; Ono K; Miyatake S; Kuroiwa T; Hao E; Vicente MG
    J Pharm Sci; 2015 Mar; 104(3):962-70. PubMed ID: 25546823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy.
    Elowitz EH; Bergland RM; Coderre JA; Joel DD; Chadha M; Chanana AD
    Neurosurgery; 1998 Mar; 42(3):463-8; discussion 468-9. PubMed ID: 9526978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.
    Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Asano T; Kirihata M; Ono K; Kuroiwa T
    J Neurooncol; 2006 Jul; 78(3):227-32. PubMed ID: 16557351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESR as a valuable tool for the investigation of the dynamics of EPC and EPC/cholesterol liposomes containing a carboranyl-nucleoside intended for BNCT.
    Rossi S; Schinazi RF; Martini G
    Biochim Biophys Acta; 2005 Jun; 1712(1):81-91. PubMed ID: 15904892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue disposition of 5-o-carboranyluracil--a novel agent for the boron neutron capture therapy of prostate cancer.
    Schinazi RF; Hurwitz SJ; Liberman I; Glazkova Y; Mourier NS; Olson J; Keane T
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):291-306. PubMed ID: 15043155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent.
    Matalka KZ; Barth RF; Staubus AE; Moeschberger ML; Coderre JA
    Radiat Res; 1994 Jan; 137(1):44-51. PubMed ID: 8265787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of sodium mercaptoundecahydrododecaborate after intravenous injection in rats.
    Mehta SC; Boudinot FD; Lu DR
    Drug Metab Dispos; 1995 Dec; 23(12):1368-71. PubMed ID: 8689945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption.
    Yang W; Barth RF; Carpenter DE; Moeschberger ML; Goodman JH
    Neurosurgery; 1996 May; 38(5):985-92. PubMed ID: 8727825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy.
    Zuo CS; Prasad PV; Busse P; Tang L; Zamenhof RG
    Med Phys; 1999 Jul; 26(7):1230-6. PubMed ID: 10435522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
    Bergenheim AT; Capala J; Roslin M; Henriksson R
    J Neurooncol; 2005 Feb; 71(3):287-93. PubMed ID: 15735919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
    Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.